Significant early and long-term improvement of neuropsychiatry symptomatology in HCV-infected patients after viral eradication with DAA

Introduction Chronic Hepatitis C infection is considered a systemic disease with extrahepatic manifestations, mainly neuropsychiatric symptoms, which is associated with a chronic low-grade inflammatory state. Hepatitis C virus (HCV) eradication is currently achieved in >98% of cases with oral direct-acting antivirals (DAA). Objectives To study potential clinical neuropsychiatric changes (mood, cognition, sleep, gastrointestinal, sickness, and motion) in HCV-infected patients after HCV eradication with DAA. Methods Design: Cohort study. Subjects: 37 HCV-infected patients, aged